Robin Marchant has practised in Skadden’s London and Moscow offices since 2005, advising private and public corporations, private equity funds and investment banks based in the U.K., the U.S., Europe and Russia on a broad range of corporate and commercial matters.

Bio

Mr. Marchant is recognized in the Russia Corporate/M&A section of Chambers Global and the Russia Corporate/M&A: High-End Capability section of Chambers Europe and also is named in IFLR1000. His practice covers cross-border mergers and acquisitions, joint ventures, private equity transactions, share capital restructurings and buybacks, corporate governance, and other corporate matters.

Mr. Marchant’s experience includes advising:

  • Renault in relation to its investments in AvtoVAZ, a leading Russian car manufacturer, including:
    • the acquisition by Renault of a 25 percent stake in AvtoVAZ; and
    • the creation of a joint venture between Renault-Nissan Alliance and Rostec giving Renault-Nissan Alliance control over AvtoVAZ and the multibillion-rouble recapitalization of AvtoVAZ;
  • Daimler AG in relation to its investment in Kamaz, Russia’s leading trucks manufacturer, and the creation of a joint venture with Rostec and Avtoinvest LLC;
  • Megapolis, a major FMCG logistics and distribution business in Russia, in the establishment of a joint venture with Philip Morris and Japan Tobacco;
  • Vardanyan, Broitman and Partners Ltd. in relation to the separation of the joint businesses of Ruben Vardanyan and Gagik Adibekyan;
  • Crispian Investments Limited in relation to its proposed sale of its investment in Norilsk Nickel;
  • Svoboda Corporation on various acquisitions, creations of joint ventures and corporate reorganisations in relation to various retail businesses, including Ulmart and Rive Gauche;
  • Fresenius Kabi AG on its proposed joint venture with Sistema PJSFC to combine their respective pharmaceutical businesses;
  • Revlon on its acquisition by way of auction of The Colomer Group from CVC Capital Partners’ funds for US$665 million;
  • Wm. Wrigley. Jr. Company on its acquisition of premium Russian chocolatier A. Korkunov, the establishment of a joint venture with Korkunov, and its later merger with Mars, Incorporated;
  • CME Group, the world’s leading derivatives marketplace, in relation to its acquisition of Elysian Systems Ltd., an independent provider of electronic trading and market technology;
  • Renaissance Partners in relation to the creation of a joint venture for the establishment of a soya protein processing plant in Finland;
  • Simon Glick Investments in relation to the restructuring and refinancing of Songbird Estates (a majority shareholder of Canary Wharf Group plc) and the creation of a warrant funding instrument;
  • TPG Capital in relation to Vita Group’s restructuring by means of a creditors’ and members’ scheme of arrangement;
  • the management of Vita Group in relation to the creation of its equity incentive scheme;
  • Berkeley Group Holdings on its return of £13 per share to shareholders and the creation of a long-term incentive plan for management;
  • Imerys SA in its US$652.8 million acquisition of S&B Industrial Minerals GmbH. Both companies are producers of industrial minerals and pigments;
  • Three Delta LLP in relation to:
    • its consideration of a possible offer for J Sainsbury plc, an owner and operator of supermarkets and convenience stores; and
    • The Delta Fund’s acquisition of the Senad Group, its acquisition of the Four Seasons Health Care Group and its subsequent restructuring involving a proposed cross-border (German/English) merger under the European Directive on Cross-Border Mergers;
  • London Clubs International plc on a Class 1 disposal of a casino and on its later takeover by Harrah’s Entertainment, Inc.;
  • Gazprombank in relation to the auction sale of a material trading interest;
  • Gazprom Neft in relation to a proposed auction sale of an oil field;
  • TMK Group, a listed Russian pipe producer, in relation to a proposed joint venture;
  • Itera Group, a private Russian gas producer, in relation to the sale of certain assets and on a proposed joint venture; and
  • funds advised by Castle Harlan, Inc., a U.S. private equity house, on its acquisition of the Polypipe Group and its subsequent restructurings and refinancings.

Credentials

Education

  • Postgraduate Diploma in Legal Practice, University of Law Guildford, 1995
  • LL.B., University of Southampton, 1992

Admissions

  • England & Wales

Robin F. Marchant

European Counsel, Mergers and Acquisitions; Private Equity
robin.marchant@skadden.com